Abintus Bio, Inc.
Biotechnology ResearchCalifornia, United States2-10 Employees
Abintus Bio, Inc. is a San Diego–based biotechnology company focused on in vivo genetic medicines that aim to engineer patients’ own cells directly inside the body. Its approach centers on a modular delivery platform designed to enable targeted, programmable cell‑type and state–specific gene expression, with initial programs targeting immune and cancer-related cells across a range of potential therapeutic areas. By pursuing off‑the‑shelf, potentially curative cell therapies, Abintus seeks to address diseases such as leukemia, solid tumors, autoimmune and infectious conditions, and genetic diseases through direct in vivo cell reprogramming. The company positions itself within the biotechnology research sector by advancing in vivo strategies that expand how immune and other cells can be modulated inside the body, backed by a history of prior technology development and clinical experience. Abintus is headquartered in San Diego, California, and operates with a relatively small team focused on developing its early programs and expanding its scientific leadership in in vivo engineering.
1-888-653-2347 
support@leadiq.com 
